Definitive Contract 75F40123C00208

Award Date 9/27/23
Potential Completion Date 9/29/27
Potential Value $1.1M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $301,019.50 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to The Research Foundation for the State University of New York (SUNY) for a project titled "Predicting the Transfer of Breast Cancer Resistant Protein (BCRP) Substrates into Human Milk Using In Vitro to In Vivo Extrapolation (IVIVE)". The contract has a period of performance through March 27, 2024 and does not have a set-aside designation. The Research Foundation for SUNY is a...
The Research Foundation for the State University of New York (RF SUNY), a non-profit organization, was awarded a $794,505.55 federal contract (Contract ID: 75F40118C10188) by the Food and Drug Administration (FDA) to develop a physiologically-based model of the female reproductive tract, including components for vaginal and intrauterine drug delivery. The contract supports new approaches to improve product manufacturing and quality. This award was not set aside. RF SUNY will be the prime...
The U.S. Department of Health and Human Services Food and Drug Administration awarded a $480,286.05 firm fixed price definitive contract to The Research Foundation For The State University Of New York (doing business as Sponsored Projects Services) to evaluate the use of longitudinal real-time (LRT) methods for post-market surveillance of adverse events. The Research Foundation For The State University Of New York is a non-profit organization that serves as the sponsored programs office for...
This federal contract award, HHSN275200403394C, was issued by the National Institute of Child Health and Human Development, a civilian agency, to The Research Foundation for the State University of New York (RF SUNY) as the prime contractor. The $6,396,260.96 definitive contract is for research on the "Effect of Hormones on Oxidative Stress" and does not have a set-aside designation. RF SUNY is a non-profit organization that provides research administration and support services to...
This is a $1,050,310 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The contract, which has no set-aside designation, is for a project titled "CDER NEURODEVELOPMENTAL AND MENTAL HEALTH OUTCOMES IN PRETERM INFANTS: EFFECTS OF EXP" with a period of performance ending on March 7, 2025. The contract was awarded under a Broad Agency...
The Department of Health and Human Services Food and Drug Administration awarded a $1,916,514.00 definitive contract to The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, to conduct research on neurodevelopmental outcomes in infants receiving opioid-replacement pharmacotherapy for neonatal opioid withdrawal syndrome (NOWS). The contract has a completion date of June 30, 2024 and does not utilize a set-aside designation. As part of this...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) in the amount of $149,999.00 to The Research Foundation for the State University of New York (SUNY), the prime contractor. The contract is for critical functions, with no set-aside designation, and has an ultimate completion date of May 25, 2018. The Research Foundation for SUNY is a non-profit organization that serves as the sponsored programs administrator for the SUNY system, managing...
This is a $584,639 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Husson University, doing business as Nescom, for a research project titled "PREDICTING THE TRANSFER OF BREAST CANCER RESISTANT PROTEIN (BCRP) SUBSTRATES INTO HUMAN MILK USING IN VITRO TO IN VIVO EXTRAPOLATION (IVIVE)." The contract, which has a completion date of September 27, 2023, does not have a set-aside designation. Nescom, a private non-profit educational institution, is...
This is a delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development to The Research Foundation For The State University Of New York, also known as Sponsored Projects Services, a non-profit organization. The contract is for $3,466,399.00 and supports the "THE PRENATAL AND CHILDHOOD MECHANISMS OF HEALTH DISPARITIES INITIAL RECRUITMENT AND RETENTION" program. It does not utilize a...
The Department of Health and Human Services Food and Drug Administration awarded a $247,100 time and materials purchase order contract to Texas A&M Agrilife Research of College Station, Texas. The contract is for a systematic review of contaminant composition in human milk and infant formula to be performed from September 2023 through December 2024. As indicated in the attached notice of intent, the FDA is sole sourcing this requirement to Texas A&M Agrilife Research based on its...

The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $1,050,000.00 definitive contract to The Research Foundation For The State University Of New York (SUNY) to conduct a study on the systemic approach to predicting the excretion of antidepressants into breast milk. This contract does not have a set-aside designation.

The original solicitation was a Broad Agency Announcement (BAA) issued by the FDA seeking advanced research and development proposals to support regulatory science and innovation across three key areas: modernizing product development and evaluation; strengthening post-market surveillance and labeling; and invigorating public health preparedness and response. The contract with SUNY is intended to advance scientific knowledge in the defined research areas to assist the FDA in accomplishing its mission to protect and promote public health.

SUNY acts as the Sponsored Programs Office for the State University of New York system, providing administrative support for externally funded research, training, and public service projects. SUNY has a history of delivering technical support and research services to various federal agencies through contract awards and subcontracts.

Generated 4/30/24, 8:07 PM